Pharma, FMCG and Real Estate Lead Gains on Indian BSE

The BSE saw a pronounced rally in sectoral leaders on September 21, driven by falling crude oil prices and softer bond yields globally. Sensex’s 0.76% rise to 74,858.99 was powered largely by strong buying in pharmaceutical, FMCG, real estate and consumer durable stocks.

Pharma and health‑care indices led the charge, with Sun Pharma, Max Healthcare and other drug makers posting notable gains. The real‑estate index followed suit, buoyed by improved sentiment in the housing market. Fast‑moving consumer goods also benefited, reflecting investor confidence in stable demand patterns.

In contrast, metal, PSU banking and automotive segments posted weaker performance, pulling down the broader Nifty Mid‑cap and Small‑cap readings, which fell 0.29% and 0.07% respectively.

Among the top individual performers were Eternal, HCL Technologies, ITC, Titan, HDFC Life and SBILife, each delivering double‑digit percentage increases. The laggards list comprised Bharti Airtel, Bajaj Finance, Power Grid, Wipro, Grasim, Infosys and Tata Steel.

The global backdrop featured a 2.25% slide in Brent crude to $101.5 a barrel as markets anticipated higher Saudi shipments. Institutional participation turned positive after a seven‑session selling streak, with foreign investors acquiring ₹599 crore and domestic institutions investing more than ₹1,000 crore during the day.

Experts note that the combination of cheaper energy, declining bond yields and improving geopolitical expectations ahead of US‑China talks has created a more balanced risk outlook, supporting sectoral recoveries.